The single-chamber prefilled syringes market size has grown rapidly in recent years. It will grow from $11.97 billion in 2025 to $13.93 billion in 2026 at a compound annual growth rate (CAGR) of 16.4%. The growth in the historic period can be attributed to growth in injectable drug formulations, increasing vaccination programs, expansion of biologics manufacturing, rising focus on patient safety standards, availability of advanced packaging materials.
The single-chamber prefilled syringes market size is expected to see rapid growth in the next few years. It will grow to $25.79 billion in 2030 at a compound annual growth rate (CAGR) of 16.7%. The growth in the forecast period can be attributed to increasing demand for self-administered injectables, rising biologics pipeline expansion, growth in home-based drug administration, increasing focus on sustainable packaging solutions, expansion of prefilled syringe adoption in emerging markets. Major trends in the forecast period include increasing adoption of prefilled drug delivery systems, rising demand for ready-to-use injectable formats, growing use of plastic-based syringe materials, expansion of vaccine and biologic packaging applications, enhanced focus on dose accuracy and patient safety.
The increasing prevalence of chronic diseases such as diabetes and cancer is contributing to the expansion of the single-chamber prefilled syringe market. Patients with diabetes who require insulin therapy when oral medications are insufficient commonly rely on single-chamber prefilled syringes for routine administration. The rising incidence of chronic diseases, including diabetes and cancer, is largely driven by increasingly sedentary lifestyles that disrupt metabolic balance and reduce long-term physiological resilience, thereby elevating the risk of chronic illness. Single-chamber prefilled syringes support the management of chronic conditions such as diabetes and cancer by enabling rapid, accurate, and convenient delivery of injectable therapies, improving treatment adherence and minimizing dosing errors during long-term care. For example, in February 2024, according to the World Health Organization, a Switzerland-based specialized agency for international public health, more than 35 million new cancer cases are projected globally by 2050, representing a 77% increase from the estimated 20 million cases recorded in 2022. Consequently, the growing burden of chronic diseases such as diabetes and cancer is driving demand for single-chamber prefilled syringes.
Companies operating in the single-chamber prefilled syringes market are increasingly focused on developing innovative polymer-based, single-dose prefilled syringe systems to address rising demand for scalable, cost-effective, and safe injectable delivery formats, particularly as biologics usage and home-based self-administration continue to grow. Polymer prefilled syringes, manufactured using materials such as cyclic olefin polymer (COP) or cyclic olefin copolymer (COC), offer excellent drug stability and chemical inertness while reducing the risk of breakage compared to traditional glass syringes. For instance, in January 2023, Sharps Technology, Inc., a US-based medical device and pharmaceutical packaging company, announced plans to introduce next-generation specialty polymer prefillable syringe systems produced in collaboration with Nephron Pharmaceuticals using COP and COC materials. These advanced syringes are designed to lower contamination risk, reduce dead space, eliminate breakage, and maintain compatibility with existing fill-finish lines. In addition, the syringes are silicone-free, helping to minimize aggregation risk and enhance overall safety and reliability.
In October 2024, Becton, Dickinson and Company, a US-based healthcare technology company, entered into a partnership with Ypsomed Holding AG for an undisclosed amount. Through this collaboration, Becton, Dickinson and Company aims to advance self-injection solutions for high-viscosity biologic drugs by integrating its BD Neopak XtraFlow glass prefillable syringe with Ypsomed’s YpsoMate 2.25 autoinjector. The partnership is intended to reduce combination product development risk, accelerate time to market, and improve usability for patients requiring next-generation biologic therapies. Ypsomed Holding AG is a Switzerland-based technology company specializing in the design and manufacture of autoinjectors and drug-delivery platforms for subcutaneous treatments.
Major companies operating in the single-chamber prefilled syringes market are Becton Dickinson and Company, Gerresheimer Glass Inc., Schott AG, Catalent Inc., Nipro Medical Corporation, Weigao Group Medical Polymer Company Limited, Stevanato Group S.p.A., Baxter International Inc., Vetter Pharma International GmbH, Terumo Corporation, Ypsomed Holding AG, SHL Medical AG, Ompi, Elcam Medical A.C.S. Ltd., Oval Medical Technologies Ltd., West Pharmaceutical Services Inc., Gerresheimer Regensburg GmbH, SCHOTT North America Inc., Vetter Pharma-Fertigung GmbH & Co. KG, Aptar Pharma Services Inc., Bespak Europe Ltd., Credence MedSystems Inc., Datwyler Pharma Packaging International Holding AG, Dätwyler Sealing Solutions AG, Fresenius Kabi AG, Haselmeier GmbH, Hikma Pharmaceuticals PLC, HTL-STREFA S.A., Intas Pharmaceuticals Ltd.
North America was the largest region in the single-chamber prefilled syringes market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-chamber prefilled syringes market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the single-chamber prefilled syringes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the single-chamber prefilled syringes market by increasing costs of imported glass tubing, specialty polymers, sterilization equipment, and precision molding components. Pharmaceutical manufacturers in North America and Europe are most affected due to dependence on imported primary packaging materials, while Asia-Pacific faces cost pressure on syringe exports. These tariffs are increasing packaging costs and impacting supply timelines. However, they are also encouraging domestic syringe manufacturing, regional material sourcing, and investment in alternative polymer-based syringe technologies.
The single-chamber prefilled syringes market research report is one of a series of new reports that provides single-chamber prefilled syringes market statistics, including single-chamber prefilled syringes industry global market size, regional shares, competitors with a single-chamber prefilled syringes market share, detailed single-chamber prefilled syringes market segments, market trends and opportunities, and any further data you may need to thrive in the single-chamber prefilled syringes industry. This single-chamber prefilled syringes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Single-chamber prefilled syringes are syringes that are pre-filled with a specific dose of medication in a single compartment. They are designed to facilitate easy and precise administration, minimizing the risk of dosing errors while enhancing convenience for both healthcare providers and patients.
The primary types of products in the category of single-chamber prefilled syringes include those made of glass and plastic. Glass-based single-chamber prefilled syringes are manufactured using glass, which is a commonly preferred material for such syringes. Plastic-based single-chamber prefilled syringes, on the other hand, utilize plastic as the preferred material. These syringes are designed for the injection of pre-filled vaccine products, biological substances, or pharmaceutical products.
The single-chamber prefilled syringes market consists of sales of glass and plastic single-chamber prefilled syringes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The single-chamber prefilled syringes market size is expected to see rapid growth in the next few years. It will grow to $25.79 billion in 2030 at a compound annual growth rate (CAGR) of 16.7%. The growth in the forecast period can be attributed to increasing demand for self-administered injectables, rising biologics pipeline expansion, growth in home-based drug administration, increasing focus on sustainable packaging solutions, expansion of prefilled syringe adoption in emerging markets. Major trends in the forecast period include increasing adoption of prefilled drug delivery systems, rising demand for ready-to-use injectable formats, growing use of plastic-based syringe materials, expansion of vaccine and biologic packaging applications, enhanced focus on dose accuracy and patient safety.
The increasing prevalence of chronic diseases such as diabetes and cancer is contributing to the expansion of the single-chamber prefilled syringe market. Patients with diabetes who require insulin therapy when oral medications are insufficient commonly rely on single-chamber prefilled syringes for routine administration. The rising incidence of chronic diseases, including diabetes and cancer, is largely driven by increasingly sedentary lifestyles that disrupt metabolic balance and reduce long-term physiological resilience, thereby elevating the risk of chronic illness. Single-chamber prefilled syringes support the management of chronic conditions such as diabetes and cancer by enabling rapid, accurate, and convenient delivery of injectable therapies, improving treatment adherence and minimizing dosing errors during long-term care. For example, in February 2024, according to the World Health Organization, a Switzerland-based specialized agency for international public health, more than 35 million new cancer cases are projected globally by 2050, representing a 77% increase from the estimated 20 million cases recorded in 2022. Consequently, the growing burden of chronic diseases such as diabetes and cancer is driving demand for single-chamber prefilled syringes.
Companies operating in the single-chamber prefilled syringes market are increasingly focused on developing innovative polymer-based, single-dose prefilled syringe systems to address rising demand for scalable, cost-effective, and safe injectable delivery formats, particularly as biologics usage and home-based self-administration continue to grow. Polymer prefilled syringes, manufactured using materials such as cyclic olefin polymer (COP) or cyclic olefin copolymer (COC), offer excellent drug stability and chemical inertness while reducing the risk of breakage compared to traditional glass syringes. For instance, in January 2023, Sharps Technology, Inc., a US-based medical device and pharmaceutical packaging company, announced plans to introduce next-generation specialty polymer prefillable syringe systems produced in collaboration with Nephron Pharmaceuticals using COP and COC materials. These advanced syringes are designed to lower contamination risk, reduce dead space, eliminate breakage, and maintain compatibility with existing fill-finish lines. In addition, the syringes are silicone-free, helping to minimize aggregation risk and enhance overall safety and reliability.
In October 2024, Becton, Dickinson and Company, a US-based healthcare technology company, entered into a partnership with Ypsomed Holding AG for an undisclosed amount. Through this collaboration, Becton, Dickinson and Company aims to advance self-injection solutions for high-viscosity biologic drugs by integrating its BD Neopak XtraFlow glass prefillable syringe with Ypsomed’s YpsoMate 2.25 autoinjector. The partnership is intended to reduce combination product development risk, accelerate time to market, and improve usability for patients requiring next-generation biologic therapies. Ypsomed Holding AG is a Switzerland-based technology company specializing in the design and manufacture of autoinjectors and drug-delivery platforms for subcutaneous treatments.
Major companies operating in the single-chamber prefilled syringes market are Becton Dickinson and Company, Gerresheimer Glass Inc., Schott AG, Catalent Inc., Nipro Medical Corporation, Weigao Group Medical Polymer Company Limited, Stevanato Group S.p.A., Baxter International Inc., Vetter Pharma International GmbH, Terumo Corporation, Ypsomed Holding AG, SHL Medical AG, Ompi, Elcam Medical A.C.S. Ltd., Oval Medical Technologies Ltd., West Pharmaceutical Services Inc., Gerresheimer Regensburg GmbH, SCHOTT North America Inc., Vetter Pharma-Fertigung GmbH & Co. KG, Aptar Pharma Services Inc., Bespak Europe Ltd., Credence MedSystems Inc., Datwyler Pharma Packaging International Holding AG, Dätwyler Sealing Solutions AG, Fresenius Kabi AG, Haselmeier GmbH, Hikma Pharmaceuticals PLC, HTL-STREFA S.A., Intas Pharmaceuticals Ltd.
North America was the largest region in the single-chamber prefilled syringes market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-chamber prefilled syringes market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the single-chamber prefilled syringes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the single-chamber prefilled syringes market by increasing costs of imported glass tubing, specialty polymers, sterilization equipment, and precision molding components. Pharmaceutical manufacturers in North America and Europe are most affected due to dependence on imported primary packaging materials, while Asia-Pacific faces cost pressure on syringe exports. These tariffs are increasing packaging costs and impacting supply timelines. However, they are also encouraging domestic syringe manufacturing, regional material sourcing, and investment in alternative polymer-based syringe technologies.
The single-chamber prefilled syringes market research report is one of a series of new reports that provides single-chamber prefilled syringes market statistics, including single-chamber prefilled syringes industry global market size, regional shares, competitors with a single-chamber prefilled syringes market share, detailed single-chamber prefilled syringes market segments, market trends and opportunities, and any further data you may need to thrive in the single-chamber prefilled syringes industry. This single-chamber prefilled syringes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Single-chamber prefilled syringes are syringes that are pre-filled with a specific dose of medication in a single compartment. They are designed to facilitate easy and precise administration, minimizing the risk of dosing errors while enhancing convenience for both healthcare providers and patients.
The primary types of products in the category of single-chamber prefilled syringes include those made of glass and plastic. Glass-based single-chamber prefilled syringes are manufactured using glass, which is a commonly preferred material for such syringes. Plastic-based single-chamber prefilled syringes, on the other hand, utilize plastic as the preferred material. These syringes are designed for the injection of pre-filled vaccine products, biological substances, or pharmaceutical products.
The single-chamber prefilled syringes market consists of sales of glass and plastic single-chamber prefilled syringes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Single-Chamber Prefilled Syringes Market Characteristics
3. Single-Chamber Prefilled Syringes Market Supply Chain Analysis
4. Global Single-Chamber Prefilled Syringes Market Trends and Strategies
5. Single-Chamber Prefilled Syringes Market Analysis of End Use Industries
7. Global Single-Chamber Prefilled Syringes Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Single-Chamber Prefilled Syringes Total Addressable Market (TAM) Analysis for the Market
9. Single-Chamber Prefilled Syringes Market Segmentation
10. Single-Chamber Prefilled Syringes Market Regional and Country Analysis
11. Asia-Pacific Single-Chamber Prefilled Syringes Market
12. China Single-Chamber Prefilled Syringes Market
13. India Single-Chamber Prefilled Syringes Market
14. Japan Single-Chamber Prefilled Syringes Market
15. Australia Single-Chamber Prefilled Syringes Market
16. Indonesia Single-Chamber Prefilled Syringes Market
17. South Korea Single-Chamber Prefilled Syringes Market
18. Taiwan Single-Chamber Prefilled Syringes Market
19. South East Asia Single-Chamber Prefilled Syringes Market
20. Western Europe Single-Chamber Prefilled Syringes Market
21. UK Single-Chamber Prefilled Syringes Market
22. Germany Single-Chamber Prefilled Syringes Market
23. France Single-Chamber Prefilled Syringes Market
24. Italy Single-Chamber Prefilled Syringes Market
25. Spain Single-Chamber Prefilled Syringes Market
26. Eastern Europe Single-Chamber Prefilled Syringes Market
27. Russia Single-Chamber Prefilled Syringes Market
28. North America Single-Chamber Prefilled Syringes Market
29. USA Single-Chamber Prefilled Syringes Market
30. Canada Single-Chamber Prefilled Syringes Market
31. South America Single-Chamber Prefilled Syringes Market
32. Brazil Single-Chamber Prefilled Syringes Market
33. Middle East Single-Chamber Prefilled Syringes Market
34. Africa Single-Chamber Prefilled Syringes Market
36. Single-Chamber Prefilled Syringes Market Competitive Landscape and Company Profiles
37. Single-Chamber Prefilled Syringes Market Other Major and Innovative Companies
40. Single-Chamber Prefilled Syringes Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Single-Chamber Prefilled Syringes Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses single-chamber prefilled syringes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for single-chamber prefilled syringes? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The single-chamber prefilled syringes market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Glass; Plastic2) By Application: Vaccine Product; Biologic; Pharmaceutical Product
3) By End-User: Hospitals And Clinics; Ambulatory Care Centers And Specialty Clinics; Home Healthcare And Self-Administration
Subsegments:
1) By Glass: Borosilicate Glass Syringes; Type I Glass Syringes; Type II Glass Syringes2) By Plastic: Polypropylene Syringes; Polycarbonate Syringes; Cyclo-olefin Polymer Syringes
Companies Mentioned: Becton Dickinson and Company; Gerresheimer Glass Inc.; Schott AG; Catalent Inc.; Nipro Medical Corporation; Weigao Group Medical Polymer Company Limited; Stevanato Group S.p.A.; Baxter International Inc.; Vetter Pharma International GmbH; Terumo Corporation; Ypsomed Holding AG; SHL Medical AG; Ompi; Elcam Medical A.C.S. Ltd.; Oval Medical Technologies Ltd.; West Pharmaceutical Services Inc.; Gerresheimer Regensburg GmbH; SCHOTT North America Inc.; Vetter Pharma-Fertigung GmbH & Co. KG; Aptar Pharma Services Inc.; Bespak Europe Ltd.; Credence MedSystems Inc.; Datwyler Pharma Packaging International Holding AG; Dätwyler Sealing Solutions AG; Fresenius Kabi AG; Haselmeier GmbH; Hikma Pharmaceuticals PLC; HTL-STREFA S.A.; Intas Pharmaceuticals Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Single-Chamber Prefilled Syringes market report include:- Becton Dickinson and Company
- Gerresheimer Glass Inc.
- Schott AG
- Catalent Inc.
- Nipro Medical Corporation
- Weigao Group Medical Polymer Company Limited
- Stevanato Group S.p.A.
- Baxter International Inc.
- Vetter Pharma International GmbH
- Terumo Corporation
- Ypsomed Holding AG
- SHL Medical AG
- Ompi
- Elcam Medical A.C.S. Ltd.
- Oval Medical Technologies Ltd.
- West Pharmaceutical Services Inc.
- Gerresheimer Regensburg GmbH
- SCHOTT North America Inc.
- Vetter Pharma-Fertigung GmbH & Co. KG
- Aptar Pharma Services Inc.
- Bespak Europe Ltd.
- Credence MedSystems Inc.
- Datwyler Pharma Packaging International Holding AG
- Dätwyler Sealing Solutions AG
- Fresenius Kabi AG
- Haselmeier GmbH
- Hikma Pharmaceuticals PLC
- HTL-STREFA S.A.
- Intas Pharmaceuticals Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 13.93 Billion |
| Forecasted Market Value ( USD | $ 25.79 Billion |
| Compound Annual Growth Rate | 16.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 30 |
